2016
Longitudinal Findings From a Randomized Clinical Trial of Naltrexone for Young Adult Heavy Drinkers
DeMartini KS, Gueorguieva R, Leeman RF, Corbin WR, Fucito LM, Kranzler HR, O’Malley S. Longitudinal Findings From a Randomized Clinical Trial of Naltrexone for Young Adult Heavy Drinkers. Journal Of Consulting And Clinical Psychology 2016, 84: 185-190. PMID: 26654213, PMCID: PMC4941818, DOI: 10.1037/ccp0000053.Peer-Reviewed Original ResearchConceptsPercent days abstinentFirst placebo-controlled trialPercent days heavy drinkingHeavy drinkingPlacebo-controlled trialLong-term outcomesHeavy drinking daysYoung adults ages 18Adults ages 18Naltrexone conditionActive medicationPlacebo groupPharmacotherapy trialsAdult heavy drinkersYoung adult heavy drinkersNonsignificant decreaseSignificant benefitsYear posttreatmentDays abstinentDrinking daysMost outcomesSingle interventionHeavy drinkersTreatment improvementAge 18
2014
Smokers’ Treatment Expectancies Predict Smoking Cessation Success
Fucito LM, Toll BA, Roos CR, King AC. Smokers’ Treatment Expectancies Predict Smoking Cessation Success. The Journal Of Smoking Cessation 2014, 11: 143-149. PMID: 27594921, PMCID: PMC5006744, DOI: 10.1017/jsc.2014.17.Peer-Reviewed Original ResearchTreatment expectanciesQuit ratesPlacebo-controlled trialSmoking cessation successBetter treatment responseSmoking cessation aidSmoking cessation outcomesHigher quit ratesLower quit ratesNaltrexone groupPlacebo groupQuit dateCessation treatmentNicotine patchCessation aidCessation successCigarette smokersParticular medicationCessation outcomesTreatment responseBehavioral counselingMedication experienceTreatment assignmentFirst monthSmokers